BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 18979960)

  • 1. Changing treatments for overactive bladder.
    Waine E; Stott M
    Nurs Times; 2008 Oct 14-20; 104(41):45-8. PubMed ID: 18979960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: Overactive bladder: a better understanding of pathophysiology, diagnosis and management. A. J. Wein and R. R. Rackley J Urol, suppl., 2006; 175: S5-S10.
    Löfgren OE
    J Urol; 2007 Oct; 178(4 Pt 1):1553; author reply 1553. PubMed ID: 17707052
    [No Abstract]   [Full Text] [Related]  

  • 3. Can we predict which patient will fail drug treatment for overactive bladder? A think tank discussion.
    Nitti VW; Kopp Z; Lin AT; Moore KH; Oefelein M; Mills IW
    Neurourol Urodyn; 2010 Apr; 29(4):652-7. PubMed ID: 20432330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of treatment of overactive bladder syndrome in women.
    Allahdin S; Oo N
    J Obstet Gynaecol; 2012 Apr; 32(3):217-21. PubMed ID: 22369391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin A in the overactive bladder: current status and future directions.
    Dmochowski R; Sand PK
    BJU Int; 2007 Feb; 99(2):247-62. PubMed ID: 17313422
    [No Abstract]   [Full Text] [Related]  

  • 6. [Overactive bladder. When it's pressing, immediate help is indicated].
    Widhalm S
    MMW Fortschr Med; 2008 May; 150(20):44-5. PubMed ID: 18605642
    [No Abstract]   [Full Text] [Related]  

  • 7. New drug information: Toviaz.
    Physician Assistants' Prescribing Reference
    JAAPA; 2009 Jun; 22(6):12. PubMed ID: 19601442
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of the overactive bladder: a review of pharmacological therapies and methods used by the urological specialist.
    Waine E; Hashim H; Abrams P
    Can J Urol; 2007 Apr; 14(2):3478-88. PubMed ID: 17466152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of overactive urinary bladder with imperative urinary incontinence in women].
    Neĭmark AI; Riapolova MV; Mel'nik MA
    Urologiia; 2010; (2):36-8. PubMed ID: 20967993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin-A: is incomplete bladder emptying predictable?
    Sahai A; Sangster P; Kalsi V; Khan MS; Fowler CJ; Dasgupta P
    BJU Int; 2009 Mar; 103(5):630-4. PubMed ID: 18990156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations for the management of urgency symptoms in patients with overactive bladder syndrome.
    Cardozo LD; Van Kerrebroeck PE; Staskin DR
    World J Urol; 2009 Dec; 27(6):755-63. PubMed ID: 19690868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of botulinum toxin type A in urological procedures.
    Lajiness MJ
    Urol Nurs; 2009; 29(6):445-50. PubMed ID: 20088238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological approach to overactive bladder and urge urinary incontinence in women: an overview.
    Cipullo LM; Cosimato C; Filippelli A; Conti V; Izzo V; Zullo F; Guida M
    Eur J Obstet Gynecol Reprod Biol; 2014 Mar; 174():27-34. PubMed ID: 24411952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin a in the overactive bladder: current status and future directions.
    Mallina R; Sahai A; Khan MS; Dasgupta P
    BJU Int; 2007 Jun; 99(6):1549-50. PubMed ID: 17537223
    [No Abstract]   [Full Text] [Related]  

  • 16. Botulinum toxin--new mechanisms, new therapeutic directions?
    Chapple C; Patel A
    Eur Urol; 2006 Apr; 49(4):606-8. PubMed ID: 16457945
    [No Abstract]   [Full Text] [Related]  

  • 17. Overactive bladder syndrome - management and treatment options.
    Arnold J; McLeod N; Thani-Gasalam R; Rashid P
    Aust Fam Physician; 2012 Nov; 41(11):878-83. PubMed ID: 23145420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study.
    Malone-Lee JG; Al-Buheissi S
    BJU Int; 2009 Apr; 103(7):931-7. PubMed ID: 19281469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticholinergic drugs versus non-drug treatment of overactive bladder syndrome in adults. A survey of a Cochrane review].
    Nordling J
    Ugeskr Laeger; 2007 Dec; 169(50):4345-7. PubMed ID: 18211791
    [No Abstract]   [Full Text] [Related]  

  • 20. [Male urinary incontinence].
    de Boer TA; Heesakkers JP
    Ned Tijdschr Geneeskd; 2008 Apr; 152(14):797-802. PubMed ID: 18491821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.